Scientists test new diabetes drug in people with kidney problems
NCT ID NCT07385547
Summary
This early-stage study aims to understand how kidney function affects the body's processing of a new long-acting diabetes drug called GL0034. Researchers will give a single dose to about 40 adults with varying levels of kidney health, from normal to severe impairment. The goal is to gather data to help doctors safely dose this medication for people with diabetes who also have kidney problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE II DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Orlando Clinical Research Center (OCRC)
NOT_YET_RECRUITINGOrlando, Florida, 32809, United States
-
Panax Clinical Research
RECRUITINGMiami Lakes, Florida, 33014, United States
-
Syneos Miami
NOT_YET_RECRUITINGMiami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.